S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10

Gilead Sciences Short Interest Ratio and Short Volume

+0.25 (+0.37 %)
(As of 10/22/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume4.50 million shs
Average Volume7.19 million shs
Market Capitalization$84.31 billion
P/E Ratio16.40
Dividend Yield4.20%

Gilead Sciences (NASDAQ:GILD) Short Interest Data

Current Short Volume24,280,000 shares
Previous Short Volume20,900,000 shares
Change Vs. Previous Month+16.17%
Dollar Volume Sold Short$1.70 billion
Short Interest Ratio / Days to Cover3.9
Last Record DateSeptember, 30 2021
Outstanding Shares1,253,809,000 shares
Percentage of Shares Shorted1.94%
Today's Trading Volume4,501,201 shares
Average Trading Volume7,194,585 shares
Today's Volume Vs. Average-37.44%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Gilead Sciences ?

Sign up to receive the latest short interest report for Gilead Sciences and its competitors with MarketBeat's FREE newsletter.

Gilead Sciences (NASDAQ:GILD) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202124,280,000 shares $1.70 billion +16.2%N/A3.9 $69.85
9/15/202120,900,000 shares $1.50 billion -6.9%N/A3.4 $71.76
8/31/202122,450,000 shares $1.63 billion -12.7%N/A3.7 $72.78
8/13/202125,700,000 shares $1.83 billion -0.1%N/A4.1 $71.16
7/30/202125,730,000 shares $1.76 billion -5.5%N/A4 $68.29
7/15/202127,220,000 shares $1.86 billion +12.3%N/A4.1 $68.30
6/30/202124,230,000 shares $1.67 billion +0.9%N/A3.5 $68.86
6/15/202124,020,000 shares $1.64 billion +1.4%N/A3.4 $68.09
5/28/202123,690,000 shares $1.57 billion -7.9%N/A3.2 $66.11
5/14/202125,720,000 shares $1.77 billion -10.2%2.1%3.3 $68.91
4/30/202128,640,000 shares $1.83 billion +10.1%2.3%3.7 $63.84
4/15/202126,010,000 shares $1.70 billion +11.0%2.1%3.4 $65.30
3/31/202123,440,000 shares $1.54 billion +4.1%1.9%2.8 $65.50
3/15/202122,520,000 shares $1.39 billion -5.5%1.8%2.4 $61.56
2/26/202123,830,000 shares $1.50 billion +3.1%1.9%2.6 $62.79
2/12/202123,110,000 shares $1.55 billion +7.1%1.9%2.6 $66.92
1/29/202121,580,000 shares $1.40 billion -3.5%1.7%2.3 $64.68
1/15/202122,370,000 shares $1.40 billion +3.7%1.8%2.3 $62.40
12/31/202021,570,000 shares $1.22 billion +22.1%1.7%2.2 $56.65
12/15/202017,670,000 shares $1.06 billion -14.8%1.4%1.9 $59.84
11/30/202020,730,000 shares $1.24 billion -4.5%1.7%2.2 $60.03
11/15/202021,710,000 shares $1.32 billion -4.4%1.7%2.3 $60.59
10/30/202022,700,000 shares $1.33 billion +10.7%1.8%2.4 $58.53
10/15/202020,500,000 shares $1.31 billion +5.9%1.6%2.1 $64.05
9/30/202019,360,000 shares $1.22 billion +7.9%1.6%2.2 $63.19

Institutional Investors Shorting Gilead Sciences (NASDAQ:GILD)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Gilead Sciences. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
10/20/2021Clear Street Markets LLC618348-43.7%$2,431.00
9/13/2021Bank of America Corp DE448,900411,100-8.4%$28,309.00
9/10/2021HBK Investments L P38,30026,600-30.5%$1,832.00
8/31/2021Pathstone Family Office LLCN/A5,085N/A$350.00
8/25/2021Marshall Wace LLPN/A16,400N/A$1,130.00
8/20/2021Jefferies Group LLC200,200200,200No Change$13,786.00
8/17/2021Wells Fargo & Company MN5,60059,000+953.6%$4,063.00
8/17/2021Walleye Trading LLC60,300114,800+90.4%$7,905.00
8/17/2021Logan Capital Management Inc.N/A4,000N/A$275.00
8/17/2021Millennium Management LLC810,8001,021,600+26.0%$70,347.00
8/17/2021Pathstone Family Office LLCN/A5,085N/A$350.00
8/17/2021Parallax Volatility Advisers L.P.225,00075,000-66.7%$5,165.00
8/17/2021Balyasny Asset Management LLCN/A12,800N/A$881.00
8/17/2021Citadel Advisors LLC4,781,5004,053,200-15.2%$279,103.00
8/16/2021Squarepoint Ops LLC531,900313,900-41.0%$21,615.00
8/16/2021Bank of America Corp DE448,900411,100-8.4%$28,309.00
8/16/2021SG3 Management LLC60,00030,000-50.0%$2,066.00
8/16/2021Royal Bank of Canada445,200245,000-45.0%$16,871.00
8/16/2021Capital Markets Trading UK LLP175,400171,400-2.3%$11,803.00
8/16/2021Credit Suisse AG494,900229,900-53.5%$15,831.00
8/16/2021Maven Securities LTD29,40018,200-38.1%$1,253.00
8/16/2021Jefferies Group LLC200,20020,020,000+9,900.0%$13,786.00
8/16/2021HBK Investments L P38,30026,600-30.5%$1,832.00
8/16/2021Capula Management Ltd147,5000-100.0%$0.00
8/16/2021Goldman Sachs Group Inc.299,900485,000+61.7%$33,397.00
8/16/2021Marshall Wace LLPN/A16,400N/A$1,130.00
8/16/2021Allianz Asset Management GmbH47,80039,000-18.4%$2,686.00
8/13/2021PEAK6 Investments LLC576,500531,300-7.8%$36,585.00
8/13/2021DCF Advisers LLC10,0000-100.0%$0.00
8/13/2021Public Sector Pension Investment BoardN/A150,000N/A$10,329.00
8/12/2021SG Americas Securities LLC2,000,0001,000,000-50.0%$3,100.00
8/12/2021JPMorgan Chase & Co.200,400192,600-3.9%$13,262.00
8/12/2021Simplex Trading LLC7,097687,400+9,585.8%$47,334.00
8/12/2021Bank of Montreal CanN/A750,000N/A$63,750.00
8/12/2021Capital Fund Management S.A.734,900558,600-24.0%$38,465.00
8/11/2021HAP Trading LLC59,10075,200+27.2%$232.00
8/11/2021Susquehanna International Group LLP7,011,0005,841,000-16.7%$402,211.00
8/10/2021Group One Trading L.P.733,600799,200+8.9%$55,033.00
8/10/2021BNP Paribas Arbitrage SA6,6563,562-46.5%$24,528.00
8/10/2021Citigroup Inc.870,000459,000-47.2%$31,607.00
8/6/2021Wolverine Trading LLC294,600318,000+7.9%$21,602.00
8/6/2021IMC Chicago LLC281,100172,100-38.8%$11,851.00
7/31/2021Private Capital Management LLC16,0000-100.0%$0.00
7/31/2021Clear Street Markets LLC250618+147.2%$4,256.00
7/31/2021Cutler Group LP8,0008,000No Change$19.00

Gilead Sciences (NASDAQ:GILD) Short Interest FAQ

Gilead Sciences (NASDAQ:GILD) Short Interest Frequently Asked Questions

What is Gilead Sciences' current short interest?

Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 24,280,000 shares of GILD short. Learn More on Gilead Sciences' current short interest.

What is a good short interest ratio for Gilead Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Gilead Sciences currently has a short interest ratio of 4.0. Learn More on a good short interest ratio for Gilead Sciences

Which institutional investors are shorting Gilead Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Clear Street Markets LLC, Bank of America Corp DE, HBK Investments L P, Pathstone Family Office LLC, Marshall Wace LLP, Jefferies Group LLC, Wells Fargo & Company MN, Walleye Trading LLC, Logan Capital Management Inc., Millennium Management LLC, Pathstone Family Office LLC, Parallax Volatility Advisers L.P., Balyasny Asset Management LLC, Citadel Advisors LLC, Squarepoint Ops LLC, Bank of America Corp DE, SG3 Management LLC, Royal Bank of Canada, Capital Markets Trading UK LLP, Credit Suisse AG, Maven Securities LTD, Jefferies Group LLC, HBK Investments L P, Capula Management Ltd, Goldman Sachs Group Inc., Marshall Wace LLP, Allianz Asset Management GmbH, PEAK6 Investments LLC, DCF Advisers LLC, Public Sector Pension Investment Board, SG Americas Securities LLC, JPMorgan Chase & Co., Simplex Trading LLC, Bank of Montreal Can, Capital Fund Management S.A., HAP Trading LLC, Susquehanna International Group LLP, Group One Trading L.P., BNP Paribas Arbitrage SA, Citigroup Inc., Wolverine Trading LLC, IMC Chicago LLC, Private Capital Management LLC, Clear Street Markets LLC, and Cutler Group LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Gilead Sciences' short interest increasing or decreasing?

Gilead Sciences saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 24,280,000 shares, an increase of 16.2% from the previous total of 20,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Gilead Sciences' short interest compare to its competitors?

0.00% of Gilead Sciences' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Gilead Sciences: Amgen Inc. (1.96%), Regeneron Pharmaceuticals, Inc. (1.76%), Vertex Pharmaceuticals Incorporated (1.97%), Biogen Inc. (1.68%), Seagen Inc. (1.78%), Alnylam Pharmaceuticals, Inc. (0.00%), Exact Sciences Co. (0.00%), Repligen Co. (3.29%), Incyte Co. (2.52%), and BioMarin Pharmaceutical Inc. (5.96%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Gilead Sciences stock?

Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. Gilead Sciences' stock is trading up $0.25 today. To short Gilead Sciences stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Gilead Sciences will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gilead Sciences?

A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further.

How often is Gilead Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is September, 30 2021.

This page was last updated on 10/24/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.